Fund details
Focuses on investing in high-potential IT and biotech companies across the Colorado Front Range and the Mid-Atlantic.
Go to profile
Partners related to this fund
Kyle Lefkoff
General Partner
With 38 years in venture capital, Mr. Lefkoff has invested in over 60 Colorado-based companies. He founded Array BioPharma in 1998 with a group of Amgen scientists and served as chairman until 2018. In 2019, Pfizer acquired Array for $11.8 billion, marking it as Colorado's largest venture-backed life sciences acquisition.
Investor scope
Investment criteria breakdown.
Investment stages
Series A
Series B+
Target regions
USA
Investment ranges
$1M - $3M
$3M - $10M
Focus areas
Biotech
Enterprise
Related unicorns
A glimpse at some of the $1B+ valuation companies backed by this fund.
Related Sector Funds
Funds investing in similar sectors.
.svg)
